cgp 12177 has been researched along with Alzheimer Disease in 2 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lemmer, B | 1 |
Langer, L | 1 |
Ohm, T | 1 |
Bohl, J | 1 |
Cowburn, RF | 1 |
Vestling, M | 1 |
Fowler, CJ | 1 |
Ravid, R | 1 |
Winblad, B | 1 |
O'Neill, C | 1 |
2 other studies available for cgp 12177 and Alzheimer Disease
Article | Year |
---|---|
Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alzheimer Disease; Binding, Competitive; Cereb | 1993 |
Disrupted beta 1-adrenoceptor-G protein coupling in the temporal cortex of patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Binding, Competitive; Female; GTP-Binding Proteins; Guanylyl Imidodiphospha | 1993 |